To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome
Sponsor: Vedic Lifesciences Pvt. Ltd.
Listed as NCT04950296, this NA trial focuses on Irritable Bowel Syndrome With Diarrhea and remains completed. Sponsored by Vedic Lifesciences Pvt. Ltd., it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Feb 2022 — Sep 2022 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Oct 2021 — Feb 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Vedic Lifesciences Pvt. Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .